TWP
BMY icon

Tyche Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Tyche Wealth Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,817
Closed -$232K – 343
2026
Q1 		$232K Buy
3,817
+5
+0.1% +$291 0.04% 314
2025
Q4 		$206K Buy
+3,812
New +$183K 0.03% 313
2025
Q3 		– Sell
-5,618
Closed -$260K – 320
2025
Q2 		$260K Sell
5,618
-703
-11% -$34.5K 0.05% 238
2025
Q1 		$386K Buy
6,321
+592
+10% +$34.5K 0.08% 165
2024
Q4 		$324K Buy
5,729
+979
+21% +$54.7K 0.07% 206
2024
Q3 		$246K Sell
4,750
-991
-17% -$46.5K 0.06% 236
2024
Q2 		$238K Sell
5,741
-902
-14% -$40.4K 0.06% 227
2024
Q1 		$360K Sell
6,643
-154
-2% -$7.84K 0.09% 176
2023
Q4 		$349K Buy
+6,797
New +$357K 0.08% 202

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tyche Wealth Partners's BMY Position: Q2 2026 in Review

Tyche Wealth Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 3,817 shares — an estimated $232K sold.

Tyche Wealth Partners first reported a position in BMY in Q4 2023 and held it in 9 quarters. The position peaked at $386K in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Tyche Wealth Partners reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Tyche Wealth Partners sold 3,817 Bristol-Myers Squibb shares in Q2 2026, an estimated $232K.
  • Tyche Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 9 quarters.
  • Tyche Wealth Partners's Bristol-Myers Squibb position peaked at $386K in Q1 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Tyche Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.